There is no fixed time for how long endocrine failure chemotherapy for prostate cancer can be resisted, which is related to the Gleason grading of prostate cancer, the patient’s status, and the treatment plan.
1. The Gleason grading of prostate cancer will affect the survival time of the patient, the higher the score, the worse the prognosis and the shorter the survival time.
2. The specific survival time is related to various factors such as whether the patient is sensitive to chemotherapy or not, and the patient’s mental state.
3. The specific survival time is also related to the treatment program, whether the treatment program is comprehensive or not, whether to adopt integrated treatment will affect the survival time.
There is no fixed period of survival time after adopting chemotherapy for endocrine failure of prostate cancer, and it is necessary to receive chemotherapy in regular hospitals, otherwise the condition will be delayed.